Skip to content
TrialScanner

NCT05878210

Evaluating the SUBLOCADE Treatment Exit Strategy

No phase registeredCompletedSUPNLead

Registry record

Lead sponsor
Indivior Inc.
Conditions
Opioid Use Disorder
Primary completion
May 9, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05878210 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05878210: Evaluating the SUBLOCADE... | TrialScanner